AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2018
Feb 6, 2018
32163_dirs_2018-02-06_b90fe2ef-8d39-4376-b480-eb2e6de5590c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2018-02-05
Reporting Person: Brannelly Paul (Executive Vice President & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-05 | Common Stock | F | 214 | $23.38 | Disposed | 134633 | Direct |
Footnotes
F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
More from COLLEGIUM PHARMACEUTICAL, INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Annual Report
2026
Feb 26